
Decades of research
into human behavioral science
Our Mission
SereneKID strives to enhance the quality of life for families and elevate the academic performance of their children.
SereneKID technology comes from decades of scientific research and technological innovation.
About the Company:
SereneKID, LLC is a spinoff of AYT, Inc. - a California company.
AYT, Inc. was established in 2008 with the primary objective of introducing innovative European healthcare technologies tailored to address various health concerns to the American market. Our team comprises distinguished European and American scientists who possess extensive expertise in the fields of neurophysiology, psychoneurology, and rehabilitation. Additionally, we collaborate with practicing physicians who specialize in neurology, ophthalmology, somnology, urogenicology, and maxillofacial rehabilitation. These are precisely the domains in which we conduct applied research and implement our advanced technologies.
Our journey in scientific exploration commenced with the development of foundational principles and optimal methodologies for treating children with cerebral palsy and facilitating the rehabilitation of post-stroke patients. Numerous neurologists have successfully defended their dissertations based on our innovations in these domains. Similarly, ophthalmologists have defended a significant number of dissertations utilizing our equipment for treating conditions like amblyopia, "school" myopia, and the rehabilitation of patients with organic eye pathologies, such as retinal dystrophy and optic nerve atrophy.
Furthermore, our state-of-the-art equipment for restoring pelvic floor muscle functions has assisted thousands of patients, both women and men, in resolving urogenital and sexological issues. Notably, our methods have evolved to the point where patients can independently utilize our devices, reducing the need for medical professional assistance.
Continuing our dedication to addressing the most pertinent areas for maintaining the health and vitality of our prospective clients, we have developed and gradually introduced new technologies to the market. These innovations encompass various aspects, such as normalizing the behavior of hyperactive children (SereneKID device), preventing the effects of stress, regulating blood pressure, mitigating snoring, rejuvenating facial appearance, and more.
The fundamental principle underpinning our developments revolves around activating natural physiological mechanisms capable of withstanding both age-related and pathological factors. While we have achieved significant milestones, our commitment to enhancing existing technologies and exploring novel avenues to improve health and sustain youthfulness and vitality remains unwavering.
The history of SereneKID development.

1988
Creation of recording techniques and algorithms for the analysis of motor behavior in laboratory animals, development of a piezoelectric sensor, conducted at the Institute of Experimental Medicine in St. Petersburg.

1999
Building upon the research and technological innovation, the team engaged in studies aimed at minimizing tremors in neurological patients diagnosed with Parkinson's disease.
​
​

2007
Embarked on a project focused on hyperactive children diagnosed with ADHD. The primary objective is to initiate the development of a specialized device designed for in-depth movement analysis.
​
​

2017
Development of the initial version of the SereneKID device and achievement of consistent positive outcomes in children with hyperactivity during testing period.
​
​
​

2021
Developing the current iteration of the SereneKID device, undergoing official electromagnetic and radiation testing, acquiring CE certification, and setting up scalable production for the device.